Normothermic Machine Perfusion: an Additional Value for Kidney Transplant Outcomes?

PHASE2Active, not recruitingINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

May 1, 2021

Primary Completion Date

May 6, 2024

Study Completion Date

May 31, 2025

Conditions
Kidney Transplant FailureChronic Kidney Failure
Interventions
PROCEDURE

Normothermic machine perfusion

Additional 2h of normothermic machine perfusion of the donor kidney with a red cell based perfusate.

Trial Locations (1)

3015GD

Erasmus MC Transplant Institute, Rotterdam

Sponsors
All Listed Sponsors
lead

Erasmus Medical Center

OTHER